Amarin Corp Plc (AMRN)

[rafunrafun]

Scripts for week ending November 12, 2021

Overall drug TRx +0.1% w/w

Vascepa
TRx 79,350; -0.6% (-488) w/w; -6.3% y/y
NRx 35,982; +1.3% (+456) w/w; -7.6% y/y
Ref 43,368; -2.1% (-944) w/w; -5.3% y/y

Lovaza (Generic & Brand)
TRx 62,680; +0.2% (+99) w/w; -1.9% y/y
NRx 30,804; +0.8% (+249) w/w; -7.3% y/y
Ref 31,875; -0.5% (-151) w/w; +3.9% y/y

Generic Vascepa
TRx 21,950; +3.8% (+802) w/w; As % of total V: 21.7%
NRx 12,446; +3.5% (+425) w/w; As % of total V: 25.7%
Ref 9,504; +4.1% (+377) w/w; As % of total V: 18.0%

Generic Vascepa by Manufacturer
Hikma - TRx 12,731 (+235); Generic share 58.0%; Total V share 12.6%
Reddy - TRx 9,219 (+567); Generic share 42.0%; Total V share 9.1%

TRx Vascepa + Generic Vascepa
TRx 101,300; +0.3% (+314)
NRx 48,428; +1.9% (+881)
Ref 52,871; -1.1% (-567)